<DOC>
	<DOCNO>NCT03072498</DOCNO>
	<brief_summary>The purpose study collect information bone marrow , blood , saliva , cheek cell skin use laboratory assist sponsor identify new way treat MDS .</brief_summary>
	<brief_title>Collection Samples From Patients With MDS</brief_title>
	<detailed_description>Goals study : The purpose study collect blood marrow sample , non-involved fibroblast , require identify unique , personalized array mutation-driven neoantigens express subject 's MDS cell assess feasibility immunize expand one patient 's T cell ex vivo investigation use adoptive cellular immunotherapy .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<criteria>Patients must meet following initial inclusion criterion : Diagnosis suspect diagnosis MDS CCUS Age 18 old Patient exclusion criterion : Currently receive within 3 month receive hypomethylating agent ( ) , lenalidomide , cytotoxic agent , within previous 4 week corticosteroid &gt; 5 mg prednisone daily immunosuppressant Previous allogenic transplant Inability provide consent Prisoners</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
</DOC>